UNSPSC 51111770: Vinfosiltine

Commodity

Code facts

NIGP codes
1

UNSPSC codes and definitions come from the UN Development Programme (managed by GS1 US), and state and local contract opportunities from the governments' procurement sites.

NIGP codes for 51111770

Definition

This classification denotes a vinca alkaloid compound and vinca-site binding agent with the molecular formula C51H72N5O10P, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier AW1UYE6Q9I, chemically known as vincaleukoblastine, o4-deacetyl-3-de(methoxycarbonyl)-3-((((1s)-1-(diethoxyphosphinyl)-2-methylpropyl)amino)carbonyl)- but generally known as vinfosiltine, which bears US NIH Compound Identifier 3086608.

Read the full definition

European Medicines Agency schedules Vinfosiltine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00065MIG. The term VINFOSILTINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 5, No. 3 1991, List 31). VINFOSILTINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule vinfosiltine under HS 29399900 and SITC 54149. As of Q4 2014, VINFOSILTINE remains the US FDA Preferred Term for this commodity.

Vinfosiltine bears US NLM identifiers UMLS ID C0084429 and NCI Concept Code C2378. SMILES: P(=O)(OCC)(OCC)C(NC(=O)C1(O)C2N(C3C(C42C2N(CC4)CC=CC2(C1O)CC)CC(C(OC)C3)C1(CC2CC(O)(CN(C2)CCC2C1[NH]C1C2CCCC1)CC)C(=O)OC)C)C(C)C.

About UNSPSC 51111770

UNSPSC 51111770 Vinfosiltine, a Commodity code, does not reflect the pharmaceutical products and emergency medical supplies actually being solicited by state and local governments in recent procurement records. Recent opportunities tagged under this code instead cover bulk pharmaceutical warehouse orders and emergency response medical equipment — notably antibiotics and overdose-reversal medications — sourced through state health departments and county public health systems. The mismatch between the code's nominal scope and actual procurement activity suggests either a data-entry error in the opportunity records or a misalignment between the code definition and current state and local buying practice under it.

The Illinois Department of Public Health executed a completed piggyback pharmaceutical contract through the MMCAP Infuse consortium awarded to Chartwell Rx LLC on August 28, 2026, totaling $2,999,999.11 over 12 months plus two renewal options, covering Doxycycline Hyclate 100mg and Ciprofloxacin Hydrochloride 500mg tablets under an IFB process. Seminole County, Florida released an IFB on June 30, 2026, for 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually with quarterly deliveries to the county's Community Health Building in Sanford; the due date listed in the record (July 26, 2023) appears to be a data entry error given the 2026 post date. The geographic concentration is limited to Illinois and Florida in the recent dataset. These records indicate that state health departments and county health systems do use this code to tag pharmaceutical and emergency medical supply buys, but the code's nominal name does not match the work; business development professionals should verify the code's actual scope before committing significant pursuit resources.

Quick answers

What is UNSPSC 51111770?

UNSPSC 51111770 is Vinfosiltine, a commodity in UNSPSC 51000000, Pharmaceutical Products incl. Contraceptives and Vaccines.

Which NIGP codes match UNSPSC 51111770?

UNSPSC 51111770 maps to 1 NIGP code, 26908 Anti-Infective Agents.

On GovTribe

See everything under UNSPSC 51111770

  • State & local contract opportunities, awards and contract vehicles under this code
  • Contacts who buy under this code
  • Ask GovTribe AI about this code